These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38057118)

  • 41. Co-administration of tacrolimus and low molecular weight heparin in patients with a history of implantation failure and elevated peripheral blood natural killer cell proportion.
    Shen P; Zhang T; Han R; Xie H; Lv Q
    J Obstet Gynaecol Res; 2023 Feb; 49(2):649-657. PubMed ID: 36436504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse obstetric and perinatal outcomes of patients with history of recurrent miscarriage: a retrospective cohort study.
    Zhang J; Liu X; Rao L; Ma R; Wu W; Chen C; Lin Y
    Fertil Steril; 2023 Sep; 120(3 Pt 2):626-634. PubMed ID: 37121567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
    Schrag D; Uno H; Rosovsky R; Rutherford C; Sanfilippo K; Villano JL; Drescher M; Jayaram N; Holmes C; Feldman L; Zattra O; Farrar-Muir H; Cronin C; Basch E; Weiss A; Connors JM;
    JAMA; 2023 Jun; 329(22):1924-1933. PubMed ID: 37266947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do Anti-Factor Xa Levels have any Impact on Pregnancy Outcome in Women with Previous Adverse Outcomes?
    Oskovi-Kaplan ZA; Erkenekli K; Oztas E; Esmer SB; Danisman N; Uygur D; Ozgu-Erdinc AS
    Z Geburtshilfe Neonatol; 2020 Dec; 224(6):355-359. PubMed ID: 32236912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study.
    Aslan K; Kasapoglu I; Cinar C; Cakir C; Avci B; Uncu G
    Reprod Sci; 2023 Nov; 30(11):3253-3260. PubMed ID: 37253934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aetiology of recurrent miscarriage and the role of adjuvant treatment in its management: a retrospective cohort review.
    Dobson SJA; Jayaprakasan KM
    J Obstet Gynaecol; 2018 Oct; 38(7):967-974. PubMed ID: 29557233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective study on IVF/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment.
    Zhang Y; Song Y; Xia X; Wang J; Qian Y; Yuan C; Mao Y; Diao F; Liu J; Ma X
    J Reprod Immunol; 2022 Sep; 153():103674. PubMed ID: 35882076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preconception anti-annexin A5 antibodies are associated with subsequent live birth in women with recurrent miscarriage: A retrospective study from China.
    Mu F; Wang C; Liu L; Wang F
    Am J Reprod Immunol; 2024 Mar; 91(3):e13822. PubMed ID: 38407361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin for assisted reproduction.
    Akhtar MA; Sur S; Raine-Fenning N; Jayaprakasan K; Thornton JG; Quenby S
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD009452. PubMed ID: 23955506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis.
    Bauersachs RM
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484221145010. PubMed ID: 36594404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for patients with acute coronary syndrome].
    Wang QK; Guo M; Zhang YQ; Song Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Oct; 22(10):628-31. PubMed ID: 20977850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study.
    Fu D; Li L; Li Y; Liu X; Chen H; Wu N; Sun G
    BMC Surg; 2022 Jun; 22(1):243. PubMed ID: 35751113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?
    Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S
    J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.
    Kumar A; Talwar A; Farley JF; Muzumdar J; Schommer JC; Balkrishnan R; Wu W
    J Am Heart Assoc; 2019 May; 8(10):e012184. PubMed ID: 31070069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature.
    Intzes S; Symeonidou M; Zagoridis K; Stamou M; Spanoudaki A; Spanoudakis E
    J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101935. PubMed ID: 33035720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.